AtaiBeckley Inc.
ATAIDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002081043
AtaiBeckley Inc. was delisted in 2026; its insiders filed their last Form 4 on Sep 11, 2026; 242 institutions reported holding it in 13F filings for Q2 2026, worth $710.7M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 1
- Last 90 days, $496.0K in total
- 13F holders
- 242
- Q2 2026, +62 vs. previous quarter
- 13F value
- $710.6M
- Reported value at the end of Q2 2026
- Superinvestors holding
- 0
- At the end of Q2 2026
Superinvestors holding ATAI, Q2 2026
No superinvestor reported holding ATAI at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by AtaiBeckley Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 (view filing)5:30 PM ET | Jul 7 | 2 days | Hershberg RobertDirector | SSale | −100.0K | $4.96 | −$496.0K | −50.0%100.0K after | 10b5-1 |
| Jun 29, 2026 (view filing) | Jun 25 | 4 days | Craig Kevin JamesChief Medical Officer | SSale | −42.6K | $4.51 | −$192.0K | −83.5%8.44K after | 10b5-1 |
| Jun 29, 2026 (view filing) | Jun 26 | 3 days | Kochendoerfer GerdChief Operating Officer | SSale | −50.0K | $5.00 | −$250.0K | −100.0%0 after | 10b5-1 |
| Apr 22, 2026 (view filing) | Apr 20 | 2 days | Craig Kevin JamesChief Medical Officer | SSale | −42.6K | $5.00 | −$212.9K | −83.5%8.44K after | 10b5-1 |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Craig Kevin JamesChief Medical Officer | SSale | −100.0K | $3.55 | −$355.0K | −92.2%8.44K after | 10b5-1 |
| Jan 6, 2026 (view filing) | Jan 2 | 4 days | Feilding-Mellen CosmoDirector | SSale | −39.6K | $3.90 | −$154.4K | −0.5%7.66M after | |
| Aug 18, 2025 (view filing)6:00 PM ET | Aug 14 | 4 days | Angermayer Christian and 1 otherDirector, 10% Owner | PPurchase | +8.68M | $2.19 | +$19.0M | +20.5%51.0M after | |
| Mar 24, 2025 (view filing)5:00 PM ET | Mar 24 | Same day | Angermayer Christian and 1 otherDirector, 10% Owner | PPurchase | +1.80M | $1.40 | +$2.52M | +4.4%42.4M after | |
| Mar 24, 2025 (view filing) | Mar 21 | 3 days | Kirpekar SahilChief Business Officer | SSale | −48.6K | $1.35 | −$65.6K | −29.6%115.6K after | |
| Mar 24, 2025 (view filing) | Mar 21 | 3 days | Craig Kevin JamesChief Medical Officer | SSale | −11.6K | $1.35 | −$15.6K | −57.8%8.44K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in AtaiBeckley Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 25,574,573 | $134.8M | 0.00% | +18,739,273+274.2% | Added |
| Deep Track Capital, LP | 14,417,442 | $76.0M | 1.12% | +2,417,442+20.1% | Added |
| Vanguard Capital Management LLC | 11,747,249 | $61.9M | 0.00% | −14,149−0.1% | Reduced |
| State Street Corp | 8,287,054 | $43.7M | 0.00% | +7,142,699+624.2% | Added |
| Geode Capital Management, LLC | 6,933,309 | $36.5M | 0.00% | +4,423,335+176.2% | Added |
| Adage Capital Partners GP, L.L.C. | 5,642,758 | $29.7M | 0.04% | 00.0% | Unchanged |
| UBS Group AG | 4,424,701 | $23.3M | 0.00% | −3,002,166−40.4% | Reduced |
| Vanguard Portfolio Management LLC | 4,106,450 | $21.6M | 0.00% | +4,106,450 | New |
| Morgan Stanley | 3,843,253 | $20.3M | 0.00% | −9,519−0.2% | Reduced |
| Candriam Luxembourg S.C.A. | 3,039,399 | $16.0M | 0.07% | −46,980−1.5% | Reduced |